09.07.2019 Views

Diagnostic Ultrasound - Abdomen and Pelvis

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Acute Hepatitis<br />

180<br />

Diagnoses: Liver<br />

• Lymphoma more common in immune-suppressed patients<br />

Steatosis (Fatty Liver)<br />

• Hepatomegaly<br />

• Diffuse, patchy or focal increase in echogenicity<br />

• Normal vessels course through "lesion"<br />

PATHOLOGY<br />

General Features<br />

• Etiology<br />

○ Viral hepatitis: Caused by 1 of 5 viral agents<br />

– Hepatitis A (HAV), B (HBV), C (HCV), D (HDV), E (HEV)<br />

viruses<br />

○ Other causes of hepatitis<br />

– Alcohol abuse<br />

– Autoimmune reactions<br />

– Metabolic disturbances<br />

– Drug-induced injury<br />

– Exposure to environmental agents<br />

– Radiation therapy<br />

• Different stages of hepatitis<br />

○ Cellular dysfunction, necrosis, fibrosis, cirrhosis<br />

• HBV: Sensitized cytotoxic T cells →hepatocyte necrosis →<br />

tissue damage<br />

• Alcoholic hepatitis: Inflammatory reaction leads to acute<br />

liver cell necrosis<br />

Staging, Grading, & Classification<br />

• Acute hepatitis<br />

○ Often self-limiting<br />

• Chronic hepatitis<br />

○ Fibrosis <strong>and</strong> cirrhosis develop in 20% HCV <strong>and</strong> 10% HBV<br />

• Staging liver fibrosis<br />

○ Liver biopsy<br />

– Current gold st<strong>and</strong>ard to stage fibrosis<br />

○ Shear-wave ultrasound <strong>and</strong> magnetic resonance<br />

elastography<br />

– Emerging noninvasive means of evaluating liver<br />

fibrosis<br />

Gross Pathologic & Surgical Features<br />

• Acute viral hepatitis: Enlarged liver + tense capsule<br />

• Chronic fulminant hepatitis: Atrophic liver<br />

• Alcoholic steatohepatitis: Enlarged, yellow, greasy liver<br />

Microscopic Features<br />

• Acute viral: Coagulative necrosis with ↑ eosinophilia<br />

• Chronic viral: Lymphocytes, macrophages, plasma cells, or<br />

piecemeal necrosis<br />

• Alcoholic hepatitis: Neutrophils/necrosis/Mallory bodies<br />

CLINICAL ISSUES<br />

Presentation<br />

• Most common signs/symptoms<br />

○ Acute hepatitis<br />

– Acute HAV: > 80% present with malaise, anorexia,<br />

fever, pain, hepatomegaly, or jaundice<br />

– Acute HCV: 75% asymptomatic at time of infection<br />

□ Fatigue, right upper quadrant pain in 25%<br />

• Clinical profile<br />

http://radiologyebook.com/<br />

○ Teenage or middle-aged patient with history of fever,<br />

RUQ pain, hepatomegaly, <strong>and</strong> jaundice<br />

• Lab data: ↑ serologic markers; ↑ liver function tests<br />

• Diagnosis based on<br />

○ Serologic markers; virological <strong>and</strong> clinical findings<br />

Demographics<br />

• Age<br />

○ Any age group (particularly teen-/middle-age)<br />

• Gender<br />

○ M = F<br />

• Epidemiology<br />

○ Viral hepatitis in USA<br />

– HAV, HBC, <strong>and</strong> HCV account for 40%, 30%, <strong>and</strong> < 5%<br />

of acute viral hepatitis, respectively<br />

– HCV most common bloodborne infection in USA<br />

□ Leading cause of HCC <strong>and</strong> liver transplant<br />

Natural History & Prognosis<br />

• Hepatitis can be self-limited or progressive <strong>and</strong> chronic in<br />

nature<br />

○ Chronic HCV infection: Occurs in 60-85%<br />

○ Chronic HBV infection: Occurs in < 10% over age 5, 50%<br />

of children, 90% of neonates<br />

– HBV accounts for 15% of chronic viral hepatitis in USA<br />

• Complications<br />

○ Relapsing <strong>and</strong> fulminant hepatitis<br />

○ Chronic viral (HBV, HCV) <strong>and</strong> alcoholic hepatitis<br />

– Cirrhosis: 10% of HBV <strong>and</strong> 20% of HCV<br />

– HCC: Particularly among carriers of HBsAg<br />

• Prognosis<br />

○ Acute viral <strong>and</strong> alcoholic: Good<br />

○ Chronic persistent hepatitis: Good<br />

○ Chronic active hepatitis: Not predictable<br />

○ Fulminant hepatitis: Poor<br />

Treatment<br />

• Acute viral hepatitis (HAV): Supportive care; IG within 2<br />

weeks of exposure, HBIG, vaccine<br />

• Chronic HCV: Directly acting antiviral agents (DAAs)<br />

○ Ledipasvir <strong>and</strong> sofosbuvir<br />

○ Paritaprevir, ritonavir, ombitasvir, dasabuvir, ribavirin<br />

○ Sofosbuvir <strong>and</strong> simeprevir, ±ribavirin<br />

• Alcoholic hepatitis: Alcohol cessation <strong>and</strong> good diet<br />

SELECTED REFERENCES<br />

1. Firneisz G: Non-alcoholic fatty liver disease <strong>and</strong> type 2 diabetes mellitus: the<br />

liver disease of our age? World J Gastroenterol. 20(27):9072-89, 2014<br />

2. Heller MT et al: The role of ultrasonography in the evaluation of diffuse liver<br />

disease. Radiol Clin North Am. 52(6):1163-75, 2014<br />

3. Sudhamsu KC: <strong>Ultrasound</strong> findings in acute viral hepatitis. Kathm<strong>and</strong>u Univ<br />

Med J (KUMJ). 4(4):415-8, 2006<br />

4. Cakir B et al: Unusual MDCT <strong>and</strong> sonography findings in fulminant hepatic<br />

failure resulting from hepatitis A infection. AJR Am J Roentgenol.<br />

185(4):1033-5, 2005<br />

5. Rubens DJ: Hepatobiliary imaging <strong>and</strong> its pitfalls. Radiol Clin North Am.<br />

42(2):257-78, 2004<br />

6. Han SH et al: Duplex Doppler ultrasound of the hepatic artery in patients<br />

with acute alcoholic hepatitis. J Clin Gastroenterol. 34(5):573-7, 2002

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!